Carrolee Barlow

Carrolee Barlow

Auto-generated profile, based on publicly available information

Carrolee Barlow

The Salk Institute for Biological Studies Laboratory of Genetics 10010 North Torrey Pines Road 92037 San Diego CA USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RSRickard Sandberg
Rickard Sandberg
RYRie Yasuda
Rie Yasuda
DPDaniel G. Pankratz
Daniel G. Pankratz
TCTodd A. Carter
Todd A. Carter
JRJo A. Del Rio
Jo A. Del Rio
CBCarrolee Barlow
Carrolee Barlow
To determine the genetic causes and molecular mechanisms responsible for neurobehavioral differences in mice, we used highly parallel gene expression profiling to detect genes that are differentially expressed between the 129SvEv and C57BL/6 mouse strains at baseline and in response to seizure. In addition, we identified genes that are differentially expressed in specific brain regions. We found that approximately 1% of expressed genes are differentially expressed between strains in at least one region of the brain and that the gene expression response to seizure is significantly different between the two inbred strains. The results lead to the identification of differences in gene expression that may account for distinct phenotypes in inbred strains and the unique functions of specific brain regions.

17 August 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CBCarrolee Barlow
Carrolee Barlow
PDPhyllis A. Dennery
Phyllis A. Dennery
MSMark K. Shigenaga
Mark K. Shigenaga
MSMark A. Smith
Mark A. Smith
JMJason D. Morrow
Jason D. Morrow
RLRodney L. Levine
Rodney L. Levine
Ataxia–telangiectasia (A-T) is characterized by a markedly increased sensitivity to ionizing radiation, increased incidence of cancer, and neurodegeneration, especially of the cerebellar Purkinje cells. Ionizing radiation oxidizes macromolecules and causes tissue damage through the generation of reactive oxygen species (ROS). We therefore hypothesized that A-T is due to oxidative damage resulting from loss of function of the A-T gene product. To assess this hypothesis, we employed an animal model of A-T, the mouse with a disrupted Atm gene. We show that organs which develop pathologic changes in the Atm -deficient mice are targets of oxidative damage, and that cerebellar Purkinje cells are particularly affected. These observations provide a mechanistic basis for the A-T phenotype and lay a rational foundation for therapeutic intervention.

18 January 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBCarrolee Barlow
Carrolee Barlow
CRCatherine Ribaut-Barassin
Catherine Ribaut-Barassin
TZTheresa A. Zwingman
Theresa A. Zwingman
APAmber J. Pope
Amber J. Pope
KBKevin D. Brown
Kevin D. Brown
AWAnthony Wynshaw-Boris
Anthony Wynshaw-Boris
We previously generated a mouse model with a mutation in the murine Atm gene that recapitulates many aspects of the childhood neurodegenerative disease ataxia-telangiectasia. Atm -deficient ( Atm −/−) mice show neurological defects detected by motor function tests including the rota-rod, open-field tests and hind-paw footprint analysis. However, no gross histological abnormalities have been observed consistently in the cerebellum of any line of Atm −/− mice analyzed in most laboratories. Therefore, it may be that the neurologic dysfunction found in these animals is associated with predegenerative lesions. We performed a detailed analysis of the cerebellar morphology in two independently generated lines of Atm −/− mice to determine whether there was evidence of neuronal abnormality. We found a significant increase in the number of lysosomes in Atm −/− mice in the absence of any detectable signs of neuronal degeneration or other ultrastructural anomalies. In addition, we found that the ATM protein is predominantly cytoplasmic in Purkinje cells and other neurons, in contrast to the nuclear localization of ATM protein observed in cultured cells. The cytoplasmic localization of ATM in Purkinje cells is similar to that found in human cerebellum. These findings suggest that ATM may be important as a cytoplasmic protein in neurons and that its absence leads to abnormalities of cytoplasmic organelles reflected as an increase in lysosomal numbers.

1 January 2001 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
DLDavid J. Lockhart
David J. Lockhart
CBCarrolee Barlow
Carrolee Barlow

15 January 2000
Verified
Journal Article
Closed access
ABA J Bishop
A J Bishop
CBC Barlow
C Barlow
AWA J Wynshaw-Boris
A J Wynshaw-Boris
RSR H Schiestl
R H Schiestl

15 May 2003 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JSJohn R Scheel
John R Scheel
LGLisa J. Garrett
Lisa J. Garrett
DADuane M. Allen
Duane M. Allen
TCTodd A. Carter
Todd A. Carter
LRLynne Randolph‐Moore
Lynne Randolph‐Moore
CBCarrolee Barlow
Carrolee Barlow
A common method for generating mice with subtle genetic manipulations uses homologous recombination (HR) in embryonic stem (ES) cells to replace a wild‐type gene with a slightly modified one. Generally, a drug resistance gene is inserted with the modified gene to select correctly targeted clones. Often, however, the presence of this drug resistance gene interferes with the normal locus and creates a null or hypomorphic allele. Flanking of the selectable marker by loxP sites followed by Cre‐mediated deletion after drug selection can overcome this problem. The simplest method used to remove a loxP‐flanked selectable marker is to breed an animal carrying a loxP‐flanked drug resistance gene to an animal that expresses Cre recombinase in the germline. To date only outbred transgenic mice are available for this purpose. This can be problematic for phenotypic analysis in many organ systems, including the brain, and for the analysis of behavior. While attempting to make 129S6/SvEvTac inbred background (isogenic to our ES cells) mice that express Cre under the control of several tissue‐specific promoters, we serendipitously generated a line that excises loxP‐flanked drug resistance genes in all tissues, including the germline. This reagent allows deletion of loxP‐flanked sequences while maintaining the mutation on an inbred background.